Scorpion Therapeutics Announces $150 Million Series C Financing to Advance Leading Clinical-stage Precision Oncology Pipeline Posted on July 16, 2024July 18, 2024 by KBD Admin
Tubulis Receives FDA Fast Track Designation for Antibody-Drug Conjugate Candidate TUB-040 in Platinum-resistant Ovarian Cancer Posted on June 27, 2024June 28, 2024 by KBD Admin
Disc Medicine Announces Underwritten Offering of Common Stock Posted on June 14, 2024June 21, 2024 by KBD Admin
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market Posted on June 14, 2024June 26, 2024 by KBD Admin
Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical Pipeline Posted on May 9, 2024June 26, 2024 by KBD Admin
Enlaza Therapeutics Raises $100 Million through Its Series A Financing, Led by the Life Sciences Group of J.P. Morgan Private Capital Posted on April 30, 2024June 21, 2024 by KBD Admin
Diagonal Therapeutics Launches with $128 Million in Financing to Pioneer a New Approach to Discovering and Developing Agonist Antibodies to Tackle the Underlying Causes of Severely Debilitating Diseases Posted on April 10, 2024April 10, 2024 by KBD Admin
Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline Posted on March 14, 2024March 15, 2024 by KBD Admin
Mirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis Posted on March 13, 2024March 15, 2024 by KBD Admin
Applied Therapeutics Announces $100 Million Private Placement Posted on February 28, 2024March 15, 2024 by KBD Admin
